Misplaced Pages

Etiracetam: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 20:59, 19 February 2007 editFuzzform (talk | contribs)Extended confirmed users5,784 editsNo edit summary← Previous edit Revision as of 21:03, 19 February 2007 edit undoFuzzform (talk | contribs)Extended confirmed users5,784 editsNo edit summaryNext edit →
Line 2: Line 2:
|IUPAC_name = ''2-(2-oxopyrrolidin-1-yl)butanamide'' |IUPAC_name = ''2-(2-oxopyrrolidin-1-yl)butanamide''
| image={{PAGENAME}}.png | image={{PAGENAME}}.png
| width = 140 | width = 100
| CAS_number= | CAS_number=
| ATC_prefix= | ATC_prefix=

Revision as of 21:03, 19 February 2007

Pharmaceutical compound
Etiracetam
File:Etiracetam.png
Clinical data
Routes of
administration		Oral
Legal status
Legal status
  • Unscheduled (US)
Identifiers
IUPAC name
  • 2-(2-oxopyrrolidin-1-yl)butanamide
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.111.445 Edit this at Wikidata
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.209 g/mol g·mol
3D model (JSmol)
SMILES
  • CCC(C(=O)N)N1CCCC1=O

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active optical form is levetiracetam.

See also


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Etiracetam: Difference between revisions Add topic